---
title: "Beijing Chunlizhengda Sets Final Dividend and Clarifies H-Share Tax Treatment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287706363.md"
description: "Beijing Chunlizhengda Medical Instruments Co., Ltd. has announced a final cash dividend of RMB 1.5 per 10 shares for the fiscal year ending December 31, 2025, to be paid in HKD for H shareholders. The payment is scheduled for June 30, 2026, with a tiered withholding tax for non-resident shareholders ranging from 10% to 20%. This decision emphasizes the company's commitment to capital returns and addresses cross-border tax considerations for investors."
datetime: "2026-05-26T22:49:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287706363.md)
  - [en](https://longbridge.com/en/news/287706363.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287706363.md)
generator: "portal-rs"
---

# Beijing Chunlizhengda Sets Final Dividend and Clarifies H-Share Tax Treatment

### Memorial Day Sale – Claim 70% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) has shared an announcement.

Beijing Chunlizhengda Medical Instruments Co., Ltd. has announced a final ordinary cash dividend of RMB 1.5 per 10 shares for the financial year ended 31 December 2025, approved at its 2024 annual general meeting and A shareholders’ class meeting. For H shareholders, the dividend will be paid in Hong Kong dollars at HKD 1.71775 per 10 shares, with an exchange rate set at RMB 1 to HKD 1.14516 and payment scheduled for 30 June 2026.

The company detailed a tiered withholding tax arrangement for non-resident enterprise and individual H shareholders and mainland investors accessing H shares via Stock Connect, with tax rates ranging from 10% to 20%. This dividend decision and clarified tax treatment provide income visibility for shareholders and underline the company’s ongoing commitment to capital returns, while also highlighting the cross-border tax considerations facing investors in its H shares.

**More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H**

Beijing Chunlizhengda Medical Instruments Co., Ltd. is a Hong Kong-listed medical device manufacturer operating through H shares. The company focuses on producing and marketing medical instruments, serving healthcare institutions and investors in mainland China and international markets through its cross-border shareholding structure.

**Average Trading Volume:** 891,607

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$6.49B

Find detailed analytics on 1858 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [688236.CN](https://longbridge.com/en/quote/688236.CN.md)
- [01858.HK](https://longbridge.com/en/quote/01858.HK.md)

## Related News & Research

- [Beijing Chunlizhengda Deploys Idle Funds Into RMB895 Million Bank Wealth Products](https://longbridge.com/en/news/290861378.md)
- [Chunlizhengda Seeks Mandate for Up to 10% H-Share Buyback](https://longbridge.com/en/news/284665850.md)
- [OKEAC: Improved H1 2026 results, stable cash, and unchanged outlook with tax dispute resolved](https://longbridge.com/en/news/297214584.md)
- [Befar Group Announces Interim Dividend and Details Cross-Border Tax Treatment](https://longbridge.com/en/news/297211082.md)
- [S&W names Hari Soor business tax partner in management shake-up](https://longbridge.com/en/news/297153692.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**